Filing Flows

Filing Flows › Evolent Health (EVH) › Next earnings date

Evolent Health (EVH) earnings: matched the estimate

Evolent Health (EVH) reported on Nov 5, 2026 and matched the EPS estimate: $0.06 against $0.06 (+0.0%). Revenue was $725M for Q3 2026, +51% year over year. It beat the EPS estimate in 60% of the quarters on record.

Last result+0.0% vs estimate
Beat rate60%

The last report

Evolent Health reported revenue of $725M for the third quarter 2026 (+51% Y/Y), net loss $23.6M. How it makes money → · Every quarter →

Evolent Health: EPS against the estimate, last 5 reportsEvolent Health: EPS against the estimate, last 5 reportsEstimateReported$0.10$0.05Nov 25$0.05$0.08Feb 26−$0.05−$0.02May 26−$0.02$0.02Aug 26$0.06$0.06Nov 26
Latest (Nov 26): Estimate $0.06, Reported $0.06.

Evolent Health's latest quarter

Evolent Health, Q3 2026: revenue $725M (+51% year over year), operating margin -0.9%, net loss $23.6M, operating cash flow $26.4M. The chart follows the revenue to costs, profit and cash.

Questions

Did Evolent Health beat earnings?

Evolent Health (EVH) reported on Nov 5, 2026 and matched the EPS estimate: $0.06 against $0.06 (+0.0%).

When does EVH report earnings?

The next date is not set yet.

Does Evolent Health usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.